Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Change in Accured Expenses (2020 - 2026)

Updated

Vivos Therapeutics (VVOS) reported Change in Accured Expenses of $929,000 for Q2 2026, up 187.6% from $323,000 a year earlier and up 643.2% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vivos Therapeutics' Change in Accured Expenses came in at $4.8 million; for FY2025, it came in at $3.62 million.

  • Change in Accured Expenses has a five-year compound annual growth rate of 50.2% (FY2020 to FY2025).
  • By year, Change in Accured Expenses came in at -$39,000 in FY2024, $422,000 in FY2023, -$941,000 in FY2022 and $1.12 million in FY2021 (+135.7%).
  • Five-year quarterly Change in Accured Expenses spans a low of -$538,000 in Q3 2022 and a high of $3.3 million in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $125,000 (Q1 2026), $3.3 million (Q4 2025) and $442,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -249.00 Mn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 55.00 Mn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -531.00 Mn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 298.00 Mn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 234.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 123.70 Mn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn 929,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 929,000.00
Mar 31, 2026 125,000.00
Dec 31, 2025 3.30 Mn
Sep 30, 2025 442,000.00
Jun 30, 2025 323,000.00
Mar 31, 2025 -450,000.00
Dec 31, 2024 254,000.00
Sep 30, 2024 -87,000.00
Jun 30, 2024 -338,000.00
Mar 31, 2024 132,000.00
Dec 31, 2023 380,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 28,000.00
Dec 31, 2022 -297,000.00
Sep 30, 2022 -538,000.00
Jun 30, 2022 -525,000.00
Mar 31, 2022 419,000.00
Dec 31, 2021 320,000.00
Sep 30, 2021 -102,000.00
API Access

Vivos Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VVOS&period=max&api_key=YOUR_API_KEY